The Oncology Institute Warrant
TOIIW
TOIIW was delisted on the 31st of July, 2026.
15 hedge funds and large institutions have $1.3M invested in The Oncology Institute Warrant in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
15% more funds holding
Funds holding: 13 → 15 (+2)
0.55% more ownership
Funds ownership: 5.6% → 6.15% (+0.55%)
53% less capital invested
Capital invested by funds: $2.77M → $1.3M (-$1.48M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$15.4K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$12.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.14K |
| 4 |
CAC
Cowen and Company
New York
|
+$25 |
| 5 |
CS
Clear Street
New York
|
+$24 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$11.7K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.27K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$67 |
TOIIW Hedge Fund Activity: Q1 2023 in Review
15 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q1 2023, worth a combined $1.3M — down 53% from $2.77M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TOIIW positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Walleye Capital, adding an estimated $15.4K. The largest seller was Man Group, exiting entirely with an estimated $11.7K sold.
- 15 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q1 2023, up from 13 in Q4 2022.
- Funds reported $1.3M of The Oncology Institute Warrant stock for Q1 2023, down 53% quarter-over-quarter.
- 4 funds opened new The Oncology Institute Warrant positions in Q1 2023 and 2 closed out, a net change of +2 holders.
- The largest The Oncology Institute Warrant buyer in Q1 2023 was Walleye Capital, an estimated $15.4K added.
- The largest The Oncology Institute Warrant seller in Q1 2023 was Man Group, an estimated $11.7K sold.
Based on aggregated 13F filings for Q1 2023.